Bristol Myers Squibb tops quarterly estimates, hikes outlook as drugmaker braces for tariffs
FILE PHOTO: The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023.
Read More
Health care industry
UnitedHealth’s stock is plunging on higher medical costs. That may mean trouble for more
UnitedHealth Group’s stock sank 20% on Thursday after the company slashed its annual profit forecast, citing higher-than-expected medical costs in
Read More
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients; shares
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials,
Read More
Why half of all workers may struggle to get weight-loss drug health insurance coverage
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.
Read More
FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approval
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly & Co.’s shares climbed in early
Read More
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage
Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone
Read More
The Covid-19 pandemic worsened a child care crisis, and it’s costing U.S. businesses
Vadym Buinov | Moment | Getty Images The Covid-19 pandemic brought to the surface both cracks and resilience in the
Read More
Oscar Health CEO Mark Bertolini is ready to take on the employer market
Mark Bertolini has helped Oscar Health move toward profitability after taking over as CEO of the health insurer a year
Read More
Eli Lilly’s big GLP-1 investment — plus, what we want from 4 portfolio stock earnings
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a
Read More
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly
Read More